Reid J. Robison, MD MBA

Psychiatrist & Chief Medical Officer @ Inner Space Research (Psychedelic Clinical Trials) & Medical Director @CFCHope (Eating Disorders)

[Reid J. Robison, MD MBA @reidrobison]

Excited to see this piece come out: "Psychedelics and the Future of Psychiatry" Welcome to the psychedelic renaissance :) https://t.co/9wabo3kEhR @psychtimes

[JAMA @JAMA_current]

Editorial: Renewed interest in psychedelics for mental health requires rigorous studies to determine their standalone therapeutic potential, as shown by Robison et al.'s trial on LSD, while addressing efficacy and safety challenges.

https://t.co/l7igC3mJmN

[Definium Therapeutics @definiumtx]

Big news in mental health! @JAMA_current published results from MindMed’s Phase 2b study of MM120 (lysergide D-tartrate) in generalized anxiety disorder (GAD) – the first randomized controlled trial of its kind for LSD in psychiatry.

More than 60 million Americans live with GAD and major depressive disorder (MDD), and far too many still struggle to find relief with existing treatments. These results mark a major milestone for psychedelic medicine and highlight the powerful potential of a new treatment option.

This isn’t just data — it’s a step toward a new era in psychiatry. We’re proud to lead the way.
Learn more: https://t.co/wPHrooL5zd

#MentalHealth #Psychedelics #ScienceMatters

[JAMA @JAMA_current]

A long-standing question about LSD is whether it works as a stand-alone treatment.

A phase 2 trial published in JAMA found that a single dose of MM120, a form of LSD, produced a dose-dependent reduction in anxiety.

Read the full results: https://t.co/m5P261cFiw

[Reid J. Robison, MD MBA @reidrobison]

@drmarkhyman @function 2025

[Reid J. Robison, MD MBA @reidrobison]

@acdmma_ @Independent_ie L

[Center for Change @CFCHope]

Reminder: Join us this Wednesday for a webinar!

Register here: https://t.co/yCdMBFDgNF

[Numinus @NuminusTraining]

Up to 1 in 5 women experience post-partum depression after giving birth. With this clinical trial, you could receive an investigational treatment for post-partum depression at no cost to you.

Click to see if you may be eligible.
https://t.co/wxV829sljL

[Center for Change @CFCHope]

Join us virtually every Thursday beginning September 5th! Learn more: https://t.co/0bHV9cFx9v

[Numinus @NuminusTraining]

If you’re overwhelmed by feelings of anxiety, anger, or sadness after bringing home your new baby, you may qualify to take part in an upcoming clinical
trial testing an investiational treatment option at
no cost to you.

Click below to learn more.
https://t.co/wxV829sljL

[Numinus @NuminusTraining]

On this #NationalPTSDAwarenessDay, educate yourself and others:
In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer & Dr. Reid Robison are joined by former Navy SEAL, Michael Higgs.
https://t.co/OXcYia9FNO

#EndTheStigma #PTSDsupport #AwarenessMatters

[Mukul Sharma @stufflistings]

Apple Watch will now track your mental health.
#WWDC23 #watchOS10

[Tricycle Day 🫠 @TricycleDay]

Chief Clinical Officer of @NuminusHealth, @reidrobison, began his career as a classic pill-slingin' psychiatrist.

But a series of eye-opening experiences permanently shifted his view on mental health, and now he’s on a mission to help folks heal from the inside out.

We spoke to Reid about his windy path into psychedelic medicine, the ongoing crusade to make psychedelic therapy accessible, and some drug-free tools he uses to overcome hopelessness and despair.

[Genevieve Jurvetson @gjurvetson]

Steve & I are thrilled to back a groundbreaking trial with MDMA-assisted therapy for cancer patients & their primary caregivers. This "dyad" or "couples" therapy marks a transformative step in mental health, recognizing the importance of healing the entire family/support system.

[Natalie Gukasyan, MD @N_Gukasyan]

Results from our multi-site study of psilocybin-assisted therapy for MDD are live today in @JAMA_current. Psilocybin had about a 12 point MADRS advantage over niacin control at day 8 that appeared durable through 6 wk follow-up. https://t.co/oUIE9ZhplV 1/

[JAMA @JAMA_current]

In this study, a 25-mg dose of #psilocybin was well tolerated and may hold promise as a treatment for major depressive disorder when combined with psychological support. https://t.co/VBHc43RjH3

[Reid J. Robison, MD MBA @reidrobison]

Roland Griffiths- Psilocybin helps:
⁃ recognize how it feels to embody the present moment
⁃ observe & let go of discomfort
⁃ transform sense of self (you are not your mind]
⁃ see that mind is capable of revealing knowledge
⁃ gain an sense of interconnectedness #PS2023

[Reid J. Robison, MD MBA @reidrobison]

Roland Griffiths: key factors of the psychedelic experience: 1) a feeling of unity 2) a sense of sacredness/preciousness 3) the noetic quality of truth. “These set the stage for enduring positive change and reduced suffering. And good god do we need to reduce suffering” #PS2023

[Natalie Gukasyan, MD @N_Gukasyan]

A much anticipated paper from Gul Dolen’s team is out today in Nature. Nardou et al. present data to support a novel hypothesis of psychedelic drug action that cuts across drug classes (i.e. “classical” 5-HT2A agonists vs. others like MDMA, ket, ibogaine). https://t.co/5ZdqppXg8F

[Center for Change @CFCHope]

Join us on Thursday, May 18, 2023 for our next webinar with @reidrobison. Register here: https://t.co/U0XV8naAxr

[Payton Nyquvest @paytonnyquvest]

Tomorrow I will be at @SXSW participating in the panel 'Music as Medicine: Music as a Tool for Healing.' 🎶

I'm honoured to be joined by Dr. Reid Robison, Charlotte James, and musician East Forest on stage to explore the integral role that music plays in psychedelic healing.